PMID- 28357821 OWN - NLM STAT- MEDLINE DCOM- 20170502 LR - 20220410 IS - 1833-3516 (Print) IS - 1833-3516 (Linking) VI - 47 IP - 1 DP - 2017 Mar TI - Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. PG - 24-32 LID - 10.28920/dhm47.1.24-32 [doi] AB - The tenth European Consensus Conference on Hyperbaric Medicine took place in April 2016, attended by a large delegation of experts from Europe and elsewhere. The focus of the meeting was the revision of the European Committee on Hyperbaric Medicine (ECHM) list of accepted indications for hyperbaric oxygen treatment (HBOT), based on a thorough review of the best available research and evidence-based medicine (EBM). For this scope, the modified GRADE system for evidence analysis, together with the DELPHI system for consensus evaluation, were adopted. The indications for HBOT, including those promulgated by the ECHM previously, were analysed by selected experts, based on an extensive review of the literature and of the available EBM studies. The indications were divided as follows: Type 1, where HBOT is strongly indicated as a primary treatment method, as it is supported by sufficiently strong evidence; Type 2, where HBOT is suggested as it is supported by acceptable levels of evidence; Type 3, where HBOT can be considered as a possible/optional measure, but it is not yet supported by sufficiently strong evidence. For each type, three levels of evidence were considered: A, when the number of randomised controlled trials (RCTs) is considered sufficient; B, when there are some RCTs in favour of the indication and there is ample expert consensus; C, when the conditions do not allow for proper RCTs but there is ample and international expert consensus. For the first time, the conference also issued 'negative' recommendations for those conditions where there is Type 1 evidence that HBOT is not indicated. The conference also gave consensus-agreed recommendations for the standard of practice of HBOT. FAU - Mathieu, Daniel AU - Mathieu D AD - European Committee for Hyperbaric Medicine. AD - Critical Care Department, Medical University and Hospital of Lille, France. FAU - Marroni, Alessandro AU - Marroni A AD - European Committee for Hyperbaric Medicine. AD - DAN Europe Research Division, Roseto degli Abruzzi, Italy. FAU - Kot, Jacek AU - Kot J AD - European Committee for Hyperbaric Medicine. AD - Head of the National Center for Hyperbaric Medicine, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Poland, jkot@gumed.edu.pl. LA - eng PT - Consensus Development Conference PT - Journal Article PT - Systematic Review PL - Australia TA - Diving Hyperb Med JT - Diving and hyperbaric medicine JID - 101282742 SB - IM EIN - Diving Hyperb Med. 2017 Jun;47(2):131-132. PMID: 28641327 CIN - Diving Hyperb Med. 2017 Jun;47(2):133. PMID: 28641328 MH - Bacterial Infections/therapy MH - Biomedical Research/standards MH - Brain Injuries/therapy MH - Burns/therapy MH - Carbon Monoxide Poisoning/therapy MH - Crush Injuries/therapy MH - Decompression Sickness/therapy MH - Embolism, Air/therapy MH - Europe MH - Evidence-Based Medicine MH - Femur Head Necrosis/therapy MH - Fractures, Open/therapy MH - Hearing Loss, Sudden/therapy MH - Humans MH - Hyperbaric Oxygenation/methods/*standards MH - Osteomyelitis/therapy MH - Radiation Injuries/therapy MH - Skin Transplantation MH - Wound Healing PMC - PMC6147240 OTO - NOTNLM OT - European Committee for Hyperbaric Medicine OT - Evidence OT - Medical conditions and problems OT - Symposium OT - Systematic review COIS- Declaration of interests nil EDAT- 2017/03/31 06:00 MHDA- 2017/05/04 06:00 PMCR- 2018/03/01 CRDT- 2017/03/31 06:00 PHST- 2017/01/02 00:00 [received] PHST- 2017/01/23 00:00 [accepted] PHST- 2017/03/31 06:00 [entrez] PHST- 2017/03/31 06:00 [pubmed] PHST- 2017/05/04 06:00 [medline] PHST- 2018/03/01 00:00 [pmc-release] AID - 10.28920/dhm47.1.24-32 [doi] PST - ppublish SO - Diving Hyperb Med. 2017 Mar;47(1):24-32. doi: 10.28920/dhm47.1.24-32.